UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 468

Sortiert nach

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Leukemia, 2015-06, Vol.29 (6), p.1223-1232

2015

Link zum Volltext

Verfügbarkeit prüfen

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

Leukemia, 2016-01, Vol.30 (1), p.136-143

2016

Link zum Volltext

Verfügbarkeit prüfen

Experimental characterization of lateral profiles of scanned proton and carbon ion pencil beams for improved beam models in ion therapy treatment planning

Physics in medicine & biology, 2011-12, Vol.56 (24), p.7813-7827

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Leukemia, 2015-05, Vol.29 (5), p.1115-1122

2015

Link zum Volltext

Verfügbarkeit prüfen

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

Leukemia, 2016-12, Vol.30 (12), p.2342-2350

2016

Link zum Volltext

Verfügbarkeit prüfen

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Annals of hematology, 2014-01, Vol.93 (1), p.81-88

2014

Link zum Volltext

Verfügbarkeit prüfen

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

Leukemia, 2016-02, Vol.30 (2), p.464-472

2016

Link zum Volltext

Verfügbarkeit prüfen

Carbon storage versus albedo change: radiative forcing of forest expansion in temperate mountainous regions of Switzerland

Biogeosciences, 2015-01, Vol.12 (2), p.467-487

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells

Leukemia, 2018-04, Vol.32 (4), p.1016-1022

2018

Link zum Volltext

Verfügbarkeit prüfen

The 2014 liver ultrasound tracking benchmark

Physics in medicine & biology, 2015-07, Vol.60 (14), p.5571-5599

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

Leukemia, 2013-11, Vol.27 (11), p.2254-2256

2013

Link zum Volltext

Verfügbarkeit prüfen

Ion beam tracking using ultrasound motion detection

Medical physics (Lancaster), 2014-04, Vol.41 (4), p.041708-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

Leukemia, 2015-11, Vol.29 (11), p.2230-2237

2015

Link zum Volltext

Verfügbarkeit prüfen

Ultrasound tracking for intra-fractional motion compensation in radiation therapy

Physica medica, 2014-07, Vol.30 (5), p.578-582

2014

Link zum Volltext

Verfügbarkeit prüfen

An Honors Curriculum Promoting Academic Careers in Emergency Medicine

Annals of emergency medicine, 2013-11, Vol.62 (5), p.S171-S171

2013

Link zum Volltext

Verfügbarkeit prüfen

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

HemaSphere, 2022-06, Vol.6 (Suppl), p.904-905

2022

Link zum Volltext

Verfügbarkeit prüfen

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

HemaSphere, 2022-06, Vol.6 (Suppl), p.903-904

2022

Link zum Volltext

Verfügbarkeit prüfen

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

HemaSphere, 2022-06, Vol.6 (Suppl), p.905-906

2022

Link zum Volltext

Verfügbarkeit prüfen

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors

Leukemia, 2012-06, Vol.26 (6), p.1321-1328

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML)

Journal of cancer research and clinical oncology, 2014-03, Vol.140 (3), p.411-417

2014

Link zum Volltext

Verfügbarkeit prüfen

91 EXPERIMENTAL CHARACTERIZATION, MODELING AND IN-VIVO IMAGING TO FOSTER HIGH PRECISION ION BEAM THERAPY AT THE HEIDELBERG ION BEAM THERAPY CENTER

Radiotherapy and oncology, 2012-03, Vol.102, p.S34-S35

2012

Link zum Volltext

Verfügbarkeit prüfen

307: Customer Service and Communication Training Initiative for Emergency Physicians Improves Patient Satisfaction Despite Crowding in the Emergency Department

Annals of emergency medicine, 2009, Vol.54 (3), p.S96-S96

2009

Link zum Volltext

Verfügbarkeit prüfen

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-08, Vol.10 (8), p.1941-1950

2022

Link zum Volltext

Verfügbarkeit prüfen

TIMBER v0.1: a conceptual framework for emulating temperature responses to tree cover change

Geoscientific Model Development, 2023-07, Vol.16 (14), p.4283-4313

2023

Link zum Volltext

Verfügbarkeit prüfen

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-11, Vol.9 (11), p.3918-3928

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 468

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(328)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(224)
Science & Technology
(212)
Life Sciences & Biomedicine
(186)
Male
(127)
Female
(125)
Biological And Medical Sciences
(99)
Middle Aged
(93)
Medical Sciences
(92)
Adult
(88)
Aged
(76)
Hematology
(75)
Oncology
(47)
Hemophilia A - Genetics
(42)
Adolescent
(38)
Mutation
(37)
Factor Viii - Genetics
(35)
Hematologic And Hematopoietic Diseases
(33)
Tumors
(33)
Prognosis
(30)
Platelet Diseases And Coagulopathies
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis

Experimental characterization of lateral profiles of scanned proton and carbon ion pencil beams for improved beam models in ion therapy treatment planning

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

Carbon storage versus albedo change: radiative forcing of forest expansion in temperate mountainous regions of Switzerland

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells

The 2014 liver ultrasound tracking benchmark

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase

Ion beam tracking using ultrasound motion detection

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

Ultrasound tracking for intra-fractional motion compensation in radiation therapy

An Honors Curriculum Promoting Academic Careers in Emergency Medicine

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors

Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML)

91 EXPERIMENTAL CHARACTERIZATION, MODELING AND IN-VIVO IMAGING TO FOSTER HIGH PRECISION ION BEAM THERAPY AT THE HEIDELBERG ION BEAM THERAPY CENTER

307: Customer Service and Communication Training Initiative for Emergency Physicians Improves Patient Satisfaction Despite Crowding in the Emergency Department

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

TIMBER v0.1: a conceptual framework for emulating temperature responses to tree cover change

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Suchergebnisse filtern